The educational tool supporting medicinal cannabis compliance helps clinicians navigate Australia’s tightly regulated medicinal cannabis prescribing pathways, which require clinical oversight and compliance with Therapeutic Goods Administration (TGA) guidelines. As demand continues to grow, healthcare professionals need access to accurate, accessible and compliant educational resources. The Compendium meets this need by providing trusted information that helps clinicians navigate an evolving regulatory landscape.

Designed exclusively for healthcare professionals and inaccessible to patients, The Compendium serves as a comprehensive medicinal cannabis knowledge base and clinical decision-support resource. It helps prescribers understand product access pathways, regulatory responsibilities and evidence-based treatment considerations, supporting more informed and compliant prescribing decisions.

Understanding Medicinal Cannabis in Australia

The use of medicinal cannabis in Australia is increasing, with over 300,000 approvals granted since 2016 under the Special Access Scheme (SAS) and Authorised Prescriber pathways. It is classified as a Schedule 8 medicine (controlled drug), meaning prescriptions must follow strict clinical criteria and legislative frameworks.

Pathways to Prescribe Medicinal Cannabis:

  • SAS Category B: For individual patient applications, reviewed by the TGA.
  • Authorised Prescriber Scheme: For clinicians with ongoing approval to treat specific patient groups.
  • Clinical Trials: Limited but regulated access for research purposes.

Prescribing must be documented and justified using clinical guidance documents, especially when recommending unregistered products not listed on the Australian Register of Therapeutic Goods (ARTG).

The Importance of Clinical Education

With the growing number of medicinal cannabis products available in Australia, clinicians require up-to-date, TGA-aligned education to prescribe responsibly. This includes understanding:

  • Indications where medicinal cannabis may be considered (e.g., chronic pain, palliative care)
  • Dosage forms and routes (e.g., oils, capsules, sprays)
  • Potential interactions and contraindications
  • Legal requirements for prescribing, documenting, and follow-up care

Integrative Healthcare and Medicinal Cannabis

As part of an integrative healthcare approach, medicinal cannabis is increasingly being explored alongside conventional and complementary therapies. Clinicians are seeking a clinical platform for integrative medicine that can support decision-making within a patient-centred care model.

Benefits of incorporating a reliable support tool into integrative care include:

  • Improved confidence in prescribing using alternative therapies
  • Clearer communication with patients about options and risks
  • More informed shared decision-making

Challenges Faced by Australian Clinicians

Many medical practitioners report feeling underprepared when it comes to prescribing medicinal cannabis. Key concerns include:

  • Limited training during medical education
  • Keeping up with changing TGA regulations
  • Differentiating between registered and unregistered products

Understanding the requirements of prescribing medicinal cannabis, including reporting and monitoring

This knowledge gap highlights the need for a TGA-compliant clinical resource that consolidates information into one accessible format.

How Clinicians Stay Compliant with TGA Guidelines

To prescribe medicinal cannabis in line with national policy, clinicians must:

  • Refer to the TGA clinical guidance documents
  • Use products that meet safety and quality standards
  • Follow approval to prescribe procedures under the Special Access Scheme or the Authorised Prescriber framework
  • Document informed consent, including risks, benefits, and treatment rationale
  • Ensure regular follow-up and monitoring of treatment outcomes

These steps are critical for maintaining best practice and ensuring patients receive safe, appropriate care.

Why a Centralised Educational Tool Matters

The increasing complexity of medicinal cannabis prescribing highlights the value of a dedicated educational tool designed for clinicians only. Key features of an effective platform should include:

  • Real-time access to TGA-aligned information
  • Product-specific summaries of medicinal cannabis products available in Australia
  • A searchable natural therapies guide for doctors in Australia
  • Downloadable support documents for prescribing and dispensing
  • Guidance on how to use medicine safely, especially with unregistered cannabis products

Such tools streamline decision-making and reduce the administrative burden for prescribers.

Empowering Clinicians with Confidence in Medicinal Cannabis Prescribing

As medicinal cannabis continues to gain traction within Australian integrative healthcare, clinicians must be equipped with the tools and knowledge to prescribe responsibly. With new products, pathways, and regulatory requirements, practitioners must remain informed and compliant while providing personalised care.

The Compendium is a trusted, educational resource that empowers clinicians to navigate medicinal cannabis prescribing with clarity and confidence, supporting both clinical integrity and patient outcomes.

Want to improve your knowledge and prescribing confidence with natural therapies and medicinal cannabis? The Compendium offers a compliant, clinician-first platform designed to help.